CSL (ASX: CSL)

CSL is a corporation based in Melbourne, Australia. Established in 1916, the firm is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. The assets are managed by the executive management team.